Vaginal Atrophy (VA) is a chronic and progressive condition that is a consequence of reduced oestrogen production. VA impacts on the quality of life, relationships, everyday activities and confidence of women sufferers. It is associated with thinning, drying and inflammation of the vaginal tissue as moisture, elasticity and blood flow is reduced. VA increases RUTIs as pH levels are high. It is experienced by 80% of all women globally and is the most common symptom of the menopause. Over 70% of BCSs will also suffer from VA due to side effects of chemotherapy and the cancer-blocker drugs they take further exacerbate VA symptoms. Current treatment options for VA, are either ineffective or poorly tolerated. In the EU and US, 3.6m patients reject existing treatments. A further, 6m women are using HT but are not happy with its safety concerns or side effects but have no alternative. Women with VA is rising, driven by aging populations, longer life expectancies, better BC survival rates and a more educated informed demographic who want hormone-free options.
This EIC-funded project will facilitate the consortium to generate a viable solution called AVeta.
AVeta -
•A safe, hormone-free solution.
•Low risk, simple treatment.
•Suitable for all patient groups.
• Natural healing therapy / drug free.
•Specific targeted therapy for VA-treats the underlying physiology cause of VA.
•Therapy is immediate and long lasting (4wks). •Long-term therapeutic benefits for VA.
•Suitable for long-term use. •No clinical side effects / safety issues.
•A universal / inclusive solution for all VA sufferers.
• Affordable.
•Improve quality of life-relief to chronic symptoms & RUTIs.
•Convenient- fits into a woman’s lifestyle- monthly, 15 min home therapy.
•Clinically prescribed, personalised, monitored treatment.
•Reduce RUTIs, vaginal infections- leading to decrease use of antibiotics.
•Improve compliance.
•Renewal prescriptions and reviews can be conducted in clinic or via telemedicine platforms.
•Improve health care outcomes –via app, subscription model and community forum.
